We have investigated disease-associated signalling pathways aiming to characterise its potential impact in PAH using cultures of HPASMCs stimulated with or without TGF-β1 or BMP4 (Additional file 1: Fig. S1A). This evidence concerns the gene TGFB1 and pulmonary arterial hypertension.